
Media Briefing: Dementia and Brain Health
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing focused on dementia, Alzheimer’s disease, and brain health. Moderated by Ellen Wilson, the session featured epidemiologist Jennifer Deal and mental‑health professor Adam Spira, who discussed how sensory and sleep factors intersect with cognitive decline and highlighted emerging prevention strategies. Deal presented evidence that hearing loss is consistently associated with increased dementia risk, noting that the relationship is likely mediated by reduced auditory clarity, social isolation, and direct brain changes. In a three‑year randomized trial, hearing‑aid interventions did not slow overall cognitive decline, but they did improve communication, lessen loneliness, and showed cognitive benefits in participants with multiple risk factors such as hypertension and diabetes. Spira explained that fragmented sleep and obstructive sleep apnea are emerging risk factors; animal studies suggest sleep deprivation can trigger Alzheimer‑like pathology, and effective sleep treatments may offer a lever for prevention. Key moments included Deal’s comment that “hearing treatment improved communication for everyone,” and Spira’s observation that “sleep disturbances may be a lever we can manipulate to prevent poor brain health outcomes.” The panel also addressed policy questions, referencing the Lancet Commission’s estimate that correcting hearing loss could prevent about 7% of dementia cases, and discussed preliminary findings that shingles vaccination may lower risk, though evidence remains limited. The briefing underscored that dementia prevention requires a multi‑modal approach—addressing hearing, sleep, cardiovascular health, physical activity, and mental well‑being—rather than a single‑factor solution. Primary‑care clinicians are positioned to screen, counsel, and coordinate care, while policymakers should consider broader public‑health initiatives targeting these modifiable risks.

Media Briefing: Ticks and Lyme Disease
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing to examine the surge in tick‑borne diseases, focusing on Lyme disease, emerging pathogens, and vaccine development. Professors Nicole Baumgart and Thomas Hart highlighted that climate warming, altered land...

Media Briefing: Malaria Vaccines, Trends, and What’s Ahead
The Johns Hopkins Malaria Research Institute hosted a media briefing to assess the latest malaria vaccine rollouts, shifting disease trends, and evolving global health financing. Speakers highlighted that malaria remains endemic in 80 countries, with 280 million cases and 600 000 deaths...

Media Briefing: MRNA Vaccines
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing to explain how messenger RNA (mRNA) vaccines work, their safety profile, and their expanding role beyond COVID‑19. Professors Andrew Pekosch and Gigi Granvall outlined the technology’s core advantage:...

3 Things to Know About Moderna’s mRNA Flu Vaccine and Its FDA Application
The video examines the FDA’s sudden reversal on Moderna’s mRNA influenza vaccine, shifting from an initial refusal to a green light for a fast‑track review aimed at adults aged 65 and older. The agency had already examined the application, but...

Media Briefing: Social Media & Mental Health
The Johns Hopkins Bloomberg School of Public Health hosted a media briefing on the evolving relationship between digital media, especially social media, and mental health. Moderated by Ellen Wilson, professors Tamar Mendelson and Johannes Thrul presented the latest research on...